Source: Virtual Congress 2021 – New insights into nontuberculous mycobacteria disease: from diagnosis to treatment



Rating:

Share or cite this content

Citations should be made in the following way:
M. Loebinger (London, United Kingdom), J. van Ingen (Nijmegen, Netherlands). The highs and lows of guideline-based therapy for NTM: a case review. Virtual Congress 2021 – New insights into nontuberculous mycobacteria disease: from diagnosis to treatment

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - The humanistic burden of asthma patients uncontrolled on ICS-LABA: a systematic literature review Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020 Epidemiology and clinical management of XDR-TB: a systematic review by TBNET Source: Eur Respir J 2009; 33: 871-881 Year: 2009 Bedaquiline in MDR/XDR-TB cases: first experience on compassionate use Source: Eur Respir J 2014; 43: 289-292 Year: 2004 Characterising asthma therapy in Scotland: Are the guidelines confusing? Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD Year: 2012 Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review Source: Eur Respir J, 53 (1) 1801030; 10.1183/13993003.01030-2018 Year: 2019 Pharmacists and medication adherence in asthma: a systematic review and meta-analysis Source: Eur Respir J, 52 (2) 1800485; 10.1183/13993003.00485-2018 Year: 2018 Clinical effectiveness of triple therapy in the management of COPD: A systematic review Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010 The use of electronic alerts in primary care to identify the over-prescription of short-acting beta2-agonists in people with asthma: a systematic review Source: International Congress 2017 – Primary care management of asthma and COPD Year: 2017 Pharmacists' interventions on clinical asthma outcomes: a systematic review Source: Eur Respir J 2016; 47: 1134-1143 Year: 2016 Effectiveness and outcomes of air travel-related TB incident follow-up: a systematic review Source: Eur Respir J, 57 (5) 2000013; 10.1183/13993003.00013-2020 Year: 2021 Effectiveness of interventions for reducing TB incidence in countries with low TB incidence: a systematic review of reviews Source: Eur Respir Rev, 28 (152) 180107; 10.1183/16000617.0107-2018 Year: 2019 Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective Source: Eur Respir J, 55 (5) 2001009; 10.1183/13993003.01009-2020 Year: 2020 Rifampicin related erythroderma in a patient with pulmonary tuberculosis with successful desensitisation: A case report and review of literature Source: International Congress 2019 – CCC Respiratory infections Year: 2019 Palliative and end-of-life care conversations in COPD: a systematic literature review Source: ERJ Open Res, 3 (2) 00068-2016; 10.1183/23120541.00068-2016 Year: 2017 Fixed-dose combination antituberculosis therapy: a systematic review and meta-analysis Source: Eur Respir J 2013; 42: 721-732 Year: 2013 Outpatient management of community acquired pneumonia using severity prediction tools: A systematic review and meta-analysis Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010 The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019 Home-based pulmonary rehabilitation and follow-up strategies in COPD patients: a systematic review Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases Year: 2019 Use of the terms “overdiagnosis” and “misdiagnosis” in the COPD literature: a rapid review Source: Breathe, 15 (1) e8; 10.1183/20734735.0354-2018 Year: 2019